Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Point-of-Care (POC) Coagulation Testing Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The point-of-care (poc) coagulation testing devices market size has demonstrated significant growth in recent years. It is forecast to grow from $2.32 billion in 2025 to $2.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The historical expansion can be attributed to the rising prevalence of coagulation disorders, the increased use of anticoagulant therapies, the expansion of decentralized healthcare settings, the growing adoption of point-of-care diagnostics, and advancements in coagulation testing technologies.
The point-of-care (poc) coagulation testing devices market size is projected for substantial expansion over the coming years. This market is anticipated to reach $3.49 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. The expansion during the forecast period is largely due to factors such as a greater need for home healthcare diagnostics, an increased emphasis on personalized medicine, the growth of telehealth-enabled diagnostic solutions, an expanding elderly demographic, and ongoing advancements in microfluidic testing platforms. Key developments anticipated in this period encompass the wider adoption of portable coagulation monitors, a heightened call for quick diagnostic testing at the point of care, the growing prevalence of home-based coagulation testing kits, improved wireless data connectivity in poc devices, and a stronger emphasis on the precision and dependability of tests.
Get A Free Sample Report With In-Depth Market Insights:
Point-of-Care (POC) Coagulation Testing Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
An increase in the occurrence of blood clotting disorders is anticipated to stimulate the expansion of the point-of-care (POC) coagulation testing devices market moving forward. These conditions hinder the blood’s capacity to clot correctly. Certain lifestyle habits, such as smoking, heavy alcohol consumption, and a sedentary existence, can contribute to blood clotting disorders. These activities can adversely affect the health of blood vessels, levels of clotting factors, and blood circulation, elevating the potential for irregular clot formation. POC coagulation testing devices allow medical providers to rapidly evaluate a patient’s coagulation status, facilitating prompt adjustments to medication dosages and treatment plans. For example, in July 2025, the National Blood Authority, an Australia-based blood management agency, reported that 2,788 patients were living with hereditary haemophilia A (HMA) in 2023–2024, an increase from 2,681 patients in 2022–2023. Thus, the growing prevalence of blood clotting disorders is a key driver for the growth of the point-of-care (POC) coagulation testing devices market.
Point-of-Care (POC) Coagulation Testing Devices Market Breakdown By Product Type And Application
The point-of-care (poc) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Coagulation Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Point-of-Care (POC) Coagulation Testing Devices Market Innovation Trends Shaping Future Development
Key companies operating within the point-of-care (POC) coagulation testing devices market are engaged in the development of immunofluorescence-based quantitative analyzers to enhance the identification and management of coagulation disorders. These analyzers function as diagnostic instruments in laboratory environments, designed to accurately measure and quantify specific proteins or molecules involved in the coagulation process, thereby assisting in the diagnosis and treatment of blood clotting conditions. For instance, in January 2023, Cipla Limited, an India-based pharmaceutical firm, introduced Cippoint. This immunofluorescence-based quantitative analyzer employs immunofluorescence technology to yield quick and precise test results within 3 to 15 minutes, thus expediting clinical decision-making processes. With its user-friendly interface, swift processing time, and comprehensive testing features, Cippoint is instrumental in boosting diagnostic efficiency, enabling timely medical judgments, and improving patient care outcomes.
Point-of-Care (POC) Coagulation Testing Devices Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the point-of-care (poc) coagulation testing devices market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, Axis-Shield Diagnostics
View The Full Point-of-Care (POC) Coagulation Testing Devices Market Report:
Point-of-Care (POC) Coagulation Testing Devices Market Geographic Spread And Regional Opportunities
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2025. The regions covered in the point-of-care (poc) coagulation testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
